The two new inactivated coronavirus vaccines developed by Sinopharm, a state-owned pharmaceutical firm, have been used on an emergency basis, and hundreds of thousands of people have been vaccinated, with no apparent adverse reactions and no one infected; among them, tens of thousands of people who went overseas to high-risk countries and regions after receiving the vaccine have so far achieved zero infection.
